Skip to main content
Search form
Search
Subscribe to newsletter +
European Association of Hospital Pharmacists
Menu
Main menu
Home
About Us
Who we are
Board
Staff
Students
Transparency
Contact Information
Call for Expressions of Interest
Members
Associate membership
News
Press Releases
EAHP Newsletters
EAHP in the news
Multimedia Gallery
Events
Calendar
Academy
Synergy Masterclass
EAHP BOOST
Congresses
General Assemblies
Accreditations
EAHP Synergy Certification Courses
Open Learning
Get Involved
Sponsors and partners
HP Practice
EAHP COVID-19 Resource Centre
European Statements of Hospital Pharmacy
What hospital pharmacists do
EAHP-ESCP Oath to Society
FIP global statements
National legislation on hospital pharmacy
Good Practice Initiatives
Common training framework
Environmental Sustainability
European Council for Pharmacy Education Accreditation
Investigation of the hospital pharmacy profession in Europe
Hospital Pharmacy Day
SIGs
Controlled Substances Management
Special Interest Group on Investigation of medication errors and efficiency in oncology
Automated Medication Management
Working Towards Eliminating Avoidable Harm
Hazardous Medicinal Products
Hospital Pharmacist’s Preparedness for in-vivo gene therapy medicinal products
Investigation of Medication Errors in Intensive Care Units
Use of Prefilled Syringes in Intensive Care Units and Operating Theaters
Policy
Resources
Consultations
Position Papers
Get involved and keep up to date
Access to Medicines
Ageing society
Infectious Diseases and AMR
ATMPs
Bar coding medicines to the single unit
Biosimilar medicines
Clinical trials
Digital Health
EMA - EAHP collaboration
European List of Emergency Medicines
Falsified Medicines
Hazardous Medicinal Products
Hospital Pharmacy Specialisation
Medical device regulation
Medicines shortages
Patient safety
Pharmaceuticals in the environment
Pharmacy preparations and compounding
Procurement
Public spending austerity
SmPC
Vaccination
Workforce
Statements
GPIs
Publications
2019 EP Election Manifesto
General information
EAHP Annual report
European Journals of Hospital Pharmacy
EAHP Surveys of HP practice
EAHP History Book
Practical Pharmaceutics
Congress presentation webcasts
2024 European Parliament Election Manifesto
Member Center
You are here
Home
Section 4: Clinical Pharmacy Services
4CPS-001
A REVISION OF PRESCRIBING PUMP INHIBITOR PRESCRIPTIONS IN INTERNAL MEDICINE AND ADDICTOLOGY DEPARTMENT
4CPS-041
DRUG SURVIVAL OF BIOLOGIC THERAPIES FOR THE TREATMENT OF PSORIASIS
4CPS-233
COVERAGE OF ENERGY AND PROTEIN NEEDS IN PATIENTS WITH KIDNEY FAILURE OR LIVER FAILURE RECEIVING TOTAL PARENTERAL NUTRITION
4CPS-231
THE USE OF CANNABIS OIL IN ONCOLOGICAL PAIN: ANALYSIS OF THE OUTCOMES IN REAL PRACTICE AT A CANCER CENTRE
4CPS-235
A MOBILE TEAM OF CLINICAL PHARMACISTS IN DIGESTIVE AND UROLOGICAL SURGERY UNITS: RESULTS AND SATISFACTION AFTER 9 MONTHS
4CPS-197
ANALYSIS OF PHARMACEUTICAL INTERVENTIONS WITH POTENTIAL TO AVOID DRUG ADVERSE EVENTS IN HOSPITALISED PATIENTS, AND CALCULATION OF AVOIDED COST
4CPS-126
ANALYSIS OF THE EFFECTIVENESS OF PERTUZUMAB AS NEOADYUVANT TREATMENT IN PATIENTS WITH HER2-POSITIVE BREAST CANCER
4CPS-118
LONG-TERM SURVIVAL IN ALK POSITIVE LUNG CANCER: A CASE REPORT
4CPS-092
COLLABORATIVE APPROACH TO IMPROVE ADHERENCE AND RETENTION IN CARE AMONG ILLICIT DRUG USERS WITH HIV/AIDS
4CPS-037
ANALYSIS OF USAGE PROFILE, EFFECTIVENESS AND SAFETY OF ALIROCUMAB IN A TERTIARY HOSPITAL
4CPS-015
PHARMACEUTICAL INTERVENTIONS IN PATIENTS TREATED WITH DIRECT-ACTING ORAL ANTICOAGULANTS ADMITTED IN INTERNAL MEDICINE
4CPS-011
THE PHARMACIST’S ROLE IN THE MANAGEMENT OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
4CPS-264
POPULATION PHARMACOKINETIC MODEL OF ETANERCEPT IN RHEUMATIC DISEASE: PROGNOSTIC FACTORS AND DOSE RECOMMENDATIONS
4CPS-262
EVALUATION OF A PHARMACIST-LED DISCHARGE SERVICE
4CPS-261
GRADE OF CHRONICITY IN NONAGENARIANS: CAN WE COMPARE NUMBER AND TYPE OF DRUG INTERVENTIONS?
Pages
« first
‹ previous
…
91
92
93
94
95
96
97
98
99
…
next ›
last »
Follow Us